Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Reducing CD33 expression to selectively protect therapeutic cells

Reducing CD33 expression to selectively protect therapeutic cells

US Patent 12398402 · Granted Aug 26, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Homology directed repair compositions for the treatment of hemoglobinopathies2025
Homology directed repair compositions for the treatment of hemoglobinopathies2025
Luteinizing hormone receptor binding agents and luteinizing hormone agonists to 2025
Anti-CD33 antibodies and uses thereof2024
Homology directed repair compositions for the treatment of hemoglobinopathies2024
Homology directed repair compositions for the treatment of hemoglobinopathies2024
Luteinizing hormone receptor binding agents and luteinizing hormone agonists to 2023
Combination of epigenetic factors and bispecific compounds targeting CD33 and CD2021
Point-of-care and/or portable platform for gene therapy2020
Point-of-care and/or portable platform for gene therapy2019
Method and microtome for producing thin sections with a section profile recordin2019
Compounds and methods for enhancing viral gene transfer to human hematopoietic c2019